298 related articles for article (PubMed ID: 10232050)
1. Hyper- and hypoaldosteronism.
Torpy DJ; Stratakis CA; Chrousos GP
Vitam Horm; 1999; 57():177-216. PubMed ID: 10232050
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of aldosterone synthesis and action in children.
White PC
Curr Opin Pediatr; 1997 Aug; 9(4):424-30. PubMed ID: 9300202
[TBL] [Abstract][Full Text] [Related]
3. Familial hyperaldosteronism.
Torpy DJ; Stratakis CA; Chrousos GP
Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
[TBL] [Abstract][Full Text] [Related]
4. [Monogenic hypertension].
Bähr V; Oelkers W; Diederich S
Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
[TBL] [Abstract][Full Text] [Related]
5. Syndromes that Mimic an Excess of Mineralocorticoids.
Sabbadin C; Armanini D
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):231-5. PubMed ID: 27251484
[TBL] [Abstract][Full Text] [Related]
6. New genetic insights in familial hyperaldosteronism.
Jackson RV; Lafferty A; Torpy DJ; Stratakis C
Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
[TBL] [Abstract][Full Text] [Related]
7. Juvenile hypertension, the role of genetically altered steroid metabolism.
Ferrari P; Bianchetti M; Frey FJ
Horm Res; 2001; 55(5):213-23. PubMed ID: 11740142
[TBL] [Abstract][Full Text] [Related]
8. Monogenic forms of human hypertension.
Toka HR; Luft FC
Semin Nephrol; 2002 Mar; 22(2):81-8. PubMed ID: 11891501
[TBL] [Abstract][Full Text] [Related]
9. Investigating mineralocorticoid hypertension.
Nussberger J
J Hypertens Suppl; 2003 May; 21(2):S25-30. PubMed ID: 12929904
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
11. Disorders of aldosterone synthesis, secretion, and cellular function.
Root AW
Curr Opin Pediatr; 2014 Aug; 26(4):480-6. PubMed ID: 24840884
[TBL] [Abstract][Full Text] [Related]
12. Inherited forms of mineralocorticoid hypertension.
Hassan-Smith Z; Stewart PM
Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):177-85. PubMed ID: 21494136
[TBL] [Abstract][Full Text] [Related]
13. [Mineralocorticoid-induced hypertension].
Hensen J; Oelkers W
Med Klin (Munich); 1997 May; 92(5):273-8. PubMed ID: 9244833
[TBL] [Abstract][Full Text] [Related]
14. Mendelian forms of human hypertension and mechanisms of disease.
Luft FC
Clin Med Res; 2003 Oct; 1(4):291-300. PubMed ID: 15931322
[TBL] [Abstract][Full Text] [Related]
15. Apparent mineralocorticoid excess: type I and type II.
Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH
Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
[TBL] [Abstract][Full Text] [Related]
16. 11Beta-hydroxylase deficiency and other syndromes of mineralocorticoid excess as a rare cause of endocrine hypertension.
Melcescu E; Phillips J; Moll G; Subauste JS; Koch CA
Horm Metab Res; 2012 Nov; 44(12):867-78. PubMed ID: 22932914
[TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism.
Gordon RD
J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
[TBL] [Abstract][Full Text] [Related]
18. Heritable forms of hypertension.
Vehaskari VM
Pediatr Nephrol; 2009 Oct; 24(10):1929-37. PubMed ID: 17647025
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders.
Magill SB
Compr Physiol; 2014 Jul; 4(3):1083-119. PubMed ID: 24944031
[TBL] [Abstract][Full Text] [Related]
20. [Low-renin hypertension and inherited mineralocorticoid diseases].
Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
